Clinical TrialsSearch results
Number of results: 1191
- Recruitment status
- Title of the study
- Health Condition
- Primary sponsor
- Date of registration
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Sulfonylurea
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Other
- A Phase 2/3 Study of SYR-322 as an Add-on to a Metformin
- Type 2 diabetes mellitus
- Takeda Pharmaceutical Company Limited
- 2009-04-01
Completed
- Effects of canagliflozin on renal oxygenation evaluated by BOLD MRI in patients with type 2 diabetes
- Type 2 diabetes
- Mori Katsuhito
- 2020-08-26
Completed
- A research study to see how well the new weekly medicine IcoSema, which is a combination of insulin icodec and semaglutide, controls blood sugar level in people with type 2 diabetes compared to weekly semaglutide (COMBINE 2)
- type 2 diabetes
- Miwa Hirotaka
- 2022-06-10
Completed
- A 52-week study comparing the efficacy and safety of once weekly IcoSema and daily insulin glargine 100 units/mL combined with insulin aspart, both treatment arms with or without oral anti-diabetic drugs, in participants with type 2 diabetes inadequately controlled with daily basal insulin. (NN1535-4593:COMBINE 3)
- type 2 diabetes
- Miwa Hirotaka
- 2021-11-27
Recruiting
- Prospective study of the efficacy of imeglimin and metformin against insulin secretion and resistance in patients with type 2 diabetes
- Type 2 diabetes
- Hamamoto Yoshiyuki
- 2022-08-16
Recruiting
- Osaka Metropolitan Diabetes & Obesity Trial 1
- Type 2 diabetes
- Emoto Masanori
- 2024-05-07
Not yet recruiting
- Effects of SGLT2 inhibitors on appetite in patients with type 2 diabetes
- type 2 diabetes
- Nin Kazuko
- 2023-03-14
Other
- Randomized controlled study for an effect of postprandial monitoring with oral hypoglycemic agent in type 2 diabetic patients
- Type 2 diabetes
- Department of Endocrinology and Metabolism, Osaka University School of Medicine
- 2009-06-10
Other
- Primary prevention of cerebrovascular and cardiovascular events with an oral antidiabetic agent in patients with type 2 diabetes at high risk for cerebral infarction
- Type 2 Diabetes
- PROFIT-J Study Steering Committee
- 2007-10-09